WallStreetZenWallStreetZen

NASDAQ: GH
Guardant Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GH

Based on 14 analysts offering 12 month price targets for Guardant Health Inc

Min Forecast
$35.00-22.53%
Avg Forecast
$53.07+17.47%
Max Forecast
$60.00+32.8%

Should I buy or sell GH stock?

Based on 14 analysts offering ratings for Guardant Health Inc.

Strong Buy
Strong Buy
10 analysts 71.43%
Buy
4 analysts 28.57%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GH's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates GH as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their GH stock forecasts and price targets.

GH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-10
lockedlocked$00.00+00.00%2025-04-10
lockedlocked$00.00+00.00%2025-03-26
lockedlocked$00.00+00.00%2025-03-06
lockedlocked$00.00+00.00%2025-02-26
Guggenheim
Bottom 13%
13
Strong BuyReiterates$56.00+23.95%2025-02-24
ScotiaBank
Bottom 6%
6
BuyMaintains$52.00+15.10%2025-02-24
Canaccord Genuity
Bottom 4%
4
Strong BuyMaintains$60.00+32.80%2025-02-24
Goldman Sachs
Top 7%
94
Strong BuyMaintains$56.00+23.95%2025-02-21
Raymond James
Bottom 3%
3
BuyReiterates$59.00+30.59%2025-02-21

1 of 2

Forecast return on equity

Is GH forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is GH forecast to generate an efficient return on assets?

Company
-17.25%
Industry
12.49%
GH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GH earnings per share forecast

What is GH's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$3.19
Avg 2 year Forecast
-$2.78
Avg 3 year Forecast
-$2.08

GH revenue forecast

What is GH's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$854.0M+15.56%
Avg 2 year Forecast
$1.0B+40.71%
Avg 3 year Forecast
$1.3B+76.69%
GH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GH revenue growth forecast

How is GH forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
19.87%
Industry
5.29%
Market
10.84%
GH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GH vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
GH$45.18$53.07+17.47%Strong Buy
CRL$104.25$188.67+80.98%Hold
RDNT$50.52$69.75+38.06%Strong Buy
EXAS$42.26$68.95+63.15%Strong Buy
SHC$10.49$16.33+55.70%Strong Buy
View Top Diagnostic & Research Stocks

Guardant Health Stock Forecast FAQ

Is Guardant Health Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: GH) stock is to Strong Buy GH stock.

Out of 14 analysts, 10 (71.43%) are recommending GH as a Strong Buy, 4 (28.57%) are recommending GH as a Buy, 0 (0%) are recommending GH as a Hold, 0 (0%) are recommending GH as a Sell, and 0 (0%) are recommending GH as a Strong Sell.

If you're new to stock investing, here's how to buy Guardant Health stock.

What is GH's earnings growth forecast for 2025-2027?

(NASDAQ: GH) Guardant Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 29.9%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 24%.

Guardant Health's earnings in 2025 is -$436,373,000.On average, 6 Wall Street analysts forecast GH's earnings for 2025 to be -$393,097,290, with the lowest GH earnings forecast at -$409,759,184, and the highest GH earnings forecast at -$378,903,824. On average, 6 Wall Street analysts forecast GH's earnings for 2026 to be -$343,518,897, with the lowest GH earnings forecast at -$390,011,754, and the highest GH earnings forecast at -$317,193,103.

In 2027, GH is forecast to generate -$256,309,307 in earnings, with the lowest earnings forecast at -$281,400,885 and the highest earnings forecast at -$225,861,237.

What is GH's revenue growth forecast for 2025-2027?

(NASDAQ: GH) Guardant Health's forecast annual revenue growth rate of 19.87% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.29%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Guardant Health's revenue in 2025 is $739,016,000.On average, 9 Wall Street analysts forecast GH's revenue for 2025 to be $105,402,651,143, with the lowest GH revenue forecast at $103,970,221,898, and the highest GH revenue forecast at $105,865,975,232. On average, 9 Wall Street analysts forecast GH's revenue for 2026 to be $128,339,291,738, with the lowest GH revenue forecast at $125,174,025,462, and the highest GH revenue forecast at $134,071,477,144.

In 2027, GH is forecast to generate $161,162,730,286 in revenue, with the lowest revenue forecast at $149,446,086,049 and the highest revenue forecast at $177,717,001,325.

What is GH's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: GH) forecast ROA is -17.25%, which is lower than the forecast US Diagnostics & Research industry average of 12.49%.

What is GH's Price Target?

According to 14 Wall Street analysts that have issued a 1 year GH price target, the average GH price target is $53.07, with the highest GH stock price forecast at $60.00 and the lowest GH stock price forecast at $35.00.

On average, Wall Street analysts predict that Guardant Health's share price could reach $53.07 by Apr 10, 2026. The average Guardant Health stock price prediction forecasts a potential upside of 17.47% from the current GH share price of $45.18.

What is GH's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: GH) Guardant Health's current Earnings Per Share (EPS) is -$3.56. On average, analysts forecast that GH's EPS will be -$3.19 for 2025, with the lowest EPS forecast at -$3.32, and the highest EPS forecast at -$3.07. On average, analysts forecast that GH's EPS will be -$2.78 for 2026, with the lowest EPS forecast at -$3.16, and the highest EPS forecast at -$2.57. In 2027, GH's EPS is forecast to hit -$2.08 (min: -$2.28, max: -$1.83).

What is GH's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: GH) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.